Gemcitabine for the treatment of non-small-cell lung cancer

ONCOLOGY

Volumn 15, Issue 3 SUPPL. 6, 2001, Pages 33-39

  Johnson, David H ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; HUMANS; LUNG NEOPLASMS; MULTICENTER STUDIES; TREATMENT OUTCOME;

EID: 0035289192     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 311:899-909, 1995.
2. Johnson DH. Evolution of cisplatin-based chemotherapy in non-small-cell lung cancer: A historical perspective and the Eastern Cooperative Oncology Group experience. Chest 117(4 suppl 1):133S-137S, 2000.
3. Gandara DR, Edelman MJ, Lara P, et al: Current status and novel therapeutic approaches in advanced non-small-cell lung cancer. ASCO Educational Book Spring:362-369, 1999.
4. Sandier AB, Nemunaitis J, Denham C, et al: Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 18:122-130, 2000.
5. Cardenal F, Lopez-Cabrerizo MP, Anton A, et al: Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 17:12-18, 1999.
6. Crinò L, Scagliotti GV, Ricci S, et al: Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project. J Clin Oncol 17:3522-3530, 1999.
7. Comella P, Frasci G, Panza N, et al: Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: Interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group. J Clin Oncol 18:1451-1457, 2000.
8. Schiller JH, Harrington D, Sandier A, et al: A randomized phase III trial of four chemotherapy regimens in advanced non-small-cell lung cancer (abstract 2). Proc Am Soc Clin Oncol 19: la, 2000.
9. Martínez J, Panizo A, Alonso MA, et al: Gemcitabine plus carboplatin in advanced non-small cell lung cancer (NSCLC): A phase I trial (abstract 1903). Proc Am Soc Clin Oncol 494a, 1998.
10. Carrato A, Garcia-Gomez V, Alberola BJ, et al: Carboplatin (CARBO) in combination with gemcitabine (GEM) in advanced non-small-cell lung cancer (NSCLC): Comparison of two consecutive phase II trials using different schedules (abstract 1922). Proc Am Soc Clin Oncol 18:498a, 1999.
11. Iaffaioli RV, Tortoriello A, Facchini G, et al: Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer. J Clin Oncol 17:921-926, 1999.